Who owns Amedisys?

Key details on Amedisys (Ticker: AMED)

Who owns Amedisys?

Is AMED a good stock to own? Find out who bought Amedisys, who sold Amedisys (AMED) stock, and who holds a large position in Amedisys.

Fund Name Number of Shares Share Valuation As Of
Kohlberg Kravis Roberts & Co 4.84M $129.52M March 31, 2015
North Tide Capital 4.00M $107.12M March 31, 2015
FMR 3.59M $96.24M March 31, 2015
KKR Asset Management 2.92M $50.21M Sept. 30, 2013
Vanguard 2.12M $56.70M March 31, 2015
EARNEST PARTNERS 2.12M $29.24M Sept. 30, 2012
BlackRock Fund Advisors 2.00M $53.50M March 31, 2015
DIMENSIONAL FUND ADVISORS 1.99M $53.41M March 31, 2015
Jefferies 1.06M $18.27M Sept. 30, 2013
JHL Capital 905000 $18.25M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 879052 $23.54M March 31, 2015
JPMORGAN CHASE & CO 867027 $14.51M June 30, 2014
Adage Capital Partners GP 840534 $9.75M June 30, 2013
D. E. Shaw & Co 820937 $21.98M March 31, 2015
Camber Capital Management 800000 $9.30M June 30, 2013
Millennium Management 775844 $20.78M March 31, 2015
NORTHERN TRUST 650595 $17.42M March 31, 2015
AQR Capital Management 614100 $6.83M March 31, 2013
STATE STREET CORPORATION 604279 $16.18M March 31, 2015
GOLDMAN SACHS 509474 $5.56M Dec. 31, 2011

Who sold Amedisys?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company March 31, 2014 985739 $14.68M
Dreman Value Management June 30, 2011 1.34M $35.70M
Thompson, Siegel, & Walmsley March 31, 2011 1.21M $42.21M
Muhlenkamp & Company Sept. 30, 2010 767030 $18.26M
Roxbury Capital Management June 30, 2005 522028 $19.20M